Novo Nordisk | NVO - Bienes

Precio De Mercado
37.08
Cambio Diario
-0.40 -1.07%
Mensual
-21.81%
Anual
-52.89%
Q1 Expectativa
35.99




Bienes Cambio Fecha
ANI Pharmaceuticals USD 1.44B 32.22M 2025-12
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Bausch Health Companies USD 26.37B 458M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Canopy Growth CAD 1.07B 165.17M 2025-09
Corcept Therapeutics USD 836.65M 13.04M 2025-12
Drreddys Laboratories INR 6.26B 161.9M 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Merck USD 129.55B 12.02B 2025-09
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Novartis USD 107.29B 2.89B 2025-09
Novo Nordisk DKK 542.9B 30.61B 2025-12
Novo Nordisk DKK 76.18B 412.98B 2025-06
Pacira USD 1.26B 32.66M 2025-12
Perrigo USD 8.54B 1.55B 2025-12
Phibro Animal Health USD 1.41B 20.03M 2025-12
Prestige Brands USD 3.49B 52.46M 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Zoetis USD 15.47B 308M 2025-12